Who owns Pantinol Plus?
Pantinol Plus is owned by Birzeit Pharmaceutical (Palestine, PEX: BPC).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Birzeit Pharmaceutical Company — over-the-counter products. Last checked .
Key facts
- Current owner
- Birzeit Pharmaceutical Company reported
- Owner HQ
- 🇵🇸 Palestine, Birzeit
- Origin
- 🇵🇸 Palestine
- Category
- Consumer health › First aid & wound care › Bandages & wound care
- Parent ticker
- PEX: BPC
- Last verified
- · 1 sources
About Pantinol Plus
Pantinol Plus is a wound cream containing 50 mg of dexpanthenol and 5 mg of chlorhexidine hydrochloride per gram, for minor injuries at risk of infection: scrapes, cuts, scratches, cracks and burns, along with intertrigo, nappy rash and the cracked nipples of nursing mothers, where it is applied after each feed and washed off before the next. Chronic wounds such as leg ulcers, pressure sores and surgical wounds are prescription-only uses.
Ownership timeline of Pantinol Plus
- Current owner Birzeit Pharmaceutical [1] reported
Where Pantinol Plus sits in Birzeit Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Birzeit Pharmaceutical ownership tree →
See the full Birzeit Pharmaceutical brand portfolio (8) →
Other brands owned by Birzeit Pharmaceutical
Birzeit Pharmaceutical controls 8 brands on Brandtree, 5 of them in consumer health.
Also in consumer health
Other brands in bandages & wound care, and who owns them
The 21 brands in bandages & wound care on Brandtree belong to 13 owners. The largest is HARTMANN, with 4.
| Brand | Owner | Owner based in |
|---|---|---|
| Atrauman | HARTMANN | 🇩🇪 Germany |
| Biatain | Coloplast | 🇩🇰 Denmark |
| Aquacel | Convatec | 🇬🇧 United Kingdom |
| Allevyn | Smith+Nephew | 🇬🇧 United Kingdom |
| Nexcare | 3M | 🇺🇸 United States |
| Hansaplast | Beiersdorf | 🇩🇪 Germany |
| Cipladine | Cipla | 🇮🇳 India |
| Makiron | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
About the owner: Birzeit Pharmaceutical
Birzeit Pharmaceutical is a publicly listed company headquartered in Birzeit, Palestine, founded in 1974. Brandtree records 8 brands under its control, and it is listed as PEX: BPC.
Birzeit Pharmaceutical Company is a Palestinian generic drug maker founded in 1974 in Birzeit, a town about ten kilometres from Ramallah. It started as a private joint stock company with $150,000 of capital and became a public joint stock company in 1979; its shares trade on the Palestine Exchange. It makes around 270 products across 16 production lines at four locations and says it carries roughly 170 brand names. It supplies the Palestinian Ministry of Health alongside pharmacies and doctors, and exports mainly to Eastern Europe. Most of its output is prescription-only; the brands listed here are the ones it sells over the counter.
Birzeit Pharmaceutical: full profile, brands and acquisition history →
🇵🇸 Pantinol Plus and other Palestinian brands
Brandtree records a controlling owner for 9 brands that began in Palestine. 1 of them (11%) are now controlled by a company headquartered in another country; Pantinol Plus is not one of them.
- Siniora — Siniora 🇯🇴
Frequently asked questions
Who is the parent company of Pantinol Plus?
The parent company of Pantinol Plus is Birzeit Pharmaceutical, a publicly listed company headquartered in Palestine.
Is Pantinol Plus Palestinian?
Yes. Pantinol Plus originated in Palestine and its owner, Birzeit Pharmaceutical, is also headquartered in Palestine.
Is Pantinol Plus still owned by Birzeit Pharmaceutical?
Yes. As of 22 September 2026, Pantinol Plus is still owned by Birzeit Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Birzeit Pharmaceutical Company — over-the-counter products — Birzeit Pharmaceutical Company, Official document; retrieved 22 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.